glp-1 multiple endocrine neoplasia Mechanism of glucose-dependent, GLP1-potentiated insulin secretion in Your guide to GLP-1 side

In this article, we will review the progress of research effects of metformin on the gastrointestinal tract in recent years in the hope of shedding light on future studies of metformin treatment and side effect mechanisms

A JAMA Network Open retrospective cohort study of 125,474 adults with overweight or obesity: Patients with T2DM: 46.5% discontinued by year one 64.1% discontinued by year two Patients without T2DM: 64.8% discontinued by year one 84.4% discontinued by year two Nearly 85% of patients without diabetes stopped taking GLP-1s within two years

Clinical implications and biomarker development Liquid biopsy for dynamic monitoring: ctDNA, circulating tumor cells (CTCs), and exosomes Liquid biopsy, through the analysis of ctDNA, CTCs, and extracellular vesicles (EVs) in peripheral blood or other body fluids, provides a minimally invasive and real-time approach for early cancer detection, treatment monitoring, and resistance mechanism identification (Fig

L.JonesM